These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29908826)

  • 1. Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials.
    Velagapudi P; Turagam M; Kolte D; Khera S; Hyder O; Gordon P; Aronow HD; Leopold J; Abbott JD
    Cardiovasc Revasc Med; 2019 Mar; 20(3):215-219. PubMed ID: 29908826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.
    Povsic TJ; Henry TD; Traverse JH; Fortuin FD; Schaer GL; Kereiakes DJ; Schatz RA; Zeiher AM; White CJ; Stewart DJ; Jolicoeur EM; Bass T; Henderson DA; Dignacco P; Gu Z; Al-Khalidi HR; Junge C; Nada A; Hunt AS; Losordo DW;
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1576-85. PubMed ID: 27491607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramyocardial, autologous CD34+ cell therapy for refractory angina.
    Losordo DW; Henry TD; Davidson C; Sup Lee J; Costa MA; Bass T; Mendelsohn F; Fortuin FD; Pepine CJ; Traverse JH; Amrani D; Ewenstein BM; Riedel N; Story K; Barker K; Povsic TJ; Harrington RA; Schatz RA;
    Circ Res; 2011 Aug; 109(4):428-36. PubMed ID: 21737787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials.
    Henry TD; Losordo DW; Traverse JH; Schatz RA; Jolicoeur EM; Schaer GL; Clare R; Chiswell K; White CJ; Fortuin FD; Kereiakes DJ; Zeiher AM; Sherman W; Hunt AS; Povsic TJ
    Eur Heart J; 2018 Jun; 39(23):2208-2216. PubMed ID: 29315376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous CD34
    Henry TD; Schaer GL; Traverse JH; Povsic TJ; Davidson C; Lee JS; Costa MA; Bass T; Mendelsohn F; Fortuin FD; Pepine CJ; Patel AN; Riedel N; Junge C; Hunt A; Kereiakes DJ; White C; Harrington RA; Schatz RA; Losordo DW;
    Cell Transplant; 2016; 25(9):1701-1711. PubMed ID: 27151378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary autologous CD34+ stem cell therapy for intractable angina.
    Wang S; Cui J; Peng W; Lu M
    Cardiology; 2010; 117(2):140-7. PubMed ID: 20975266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.
    Losordo DW; Schatz RA; White CJ; Udelson JE; Veereshwarayya V; Durgin M; Poh KK; Weinstein R; Kearney M; Chaudhry M; Burg A; Eaton L; Heyd L; Thorne T; Shturman L; Hoffmeister P; Story K; Zak V; Dowling D; Traverse JH; Olson RE; Flanagan J; Sodano D; Murayama T; Kawamoto A; Kusano KF; Wollins J; Welt F; Shah P; Soukas P; Asahara T; Henry TD
    Circulation; 2007 Jun; 115(25):3165-72. PubMed ID: 17562958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study.
    Povsic TJ; Junge C; Nada A; Schatz RA; Harrington RA; Davidson CJ; Fortuin FD; Kereiakes DJ; Mendelsohn FO; Sherman W; Schaer GL; White CJ; Stewart D; Story K; Losordo DW; Henry TD
    Am Heart J; 2013 Jun; 165(6):854-861.e2. PubMed ID: 23708155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34+ autologous human stem cells in treating refractory angina.
    Perin EC; Willerson JT
    Circ Res; 2011 Aug; 109(4):351-2. PubMed ID: 21817161
    [No Abstract]   [Full Text] [Related]  

  • 10. A comprehensive meta-analysis of stem cell therapy for chronic angina.
    Shah R; Latham SB; Khan SA; Shahreyar M; Hwang I; Jovin IS
    Clin Cardiol; 2018 Apr; 41(4):525-531. PubMed ID: 29664162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34
    Johnson GL; Henry TD; Povsic TJ; Losordo DW; Garberich RF; Stanberry LI; Strauss CE; Traverse JH
    Stem Cells Transl Med; 2020 Oct; 9(10):1147-1152. PubMed ID: 32531108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis.
    Khan AR; Farid TA; Pathan A; Tripathi A; Ghafghazi S; Wysoczynski M; Bolli R
    Circ Res; 2016 Mar; 118(6):984-93. PubMed ID: 26838794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell therapy is a promising tool for refractory angina: a meta-analysis of randomized controlled trials.
    Li N; Yang YJ; Zhang Q; Jin C; Wang H; Qian HY
    Can J Cardiol; 2013 Aug; 29(8):908-14. PubMed ID: 23465346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: an analysis from ACT34-CMI.
    Povsic TJ; Losordo DW; Story K; Junge CE; Schatz RA; Harrington RA; Henry TD
    Am Heart J; 2012 Nov; 164(5):689-697.e3. PubMed ID: 23137499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
    Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
    Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Cell Therapy on Cardiovascular Outcomes in Patients With Refractory Angina.
    Jones DA; Weeraman D; Colicchia M; Hussain MA; Veerapen D; Andiapen M; Rathod KS; Baumbach A; Mathur A
    Circ Res; 2019 Jun; 124(12):1786-1795. PubMed ID: 30922167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmyocardial laser revascularization versus medical therapy for refractory angina.
    Briones E; Lacalle JR; Marin-Leon I; Rueda JR
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD003712. PubMed ID: 25721946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive Coronary Arteries.
    Corban MT; Toya T; Albers D; Sebaali F; Lewis BR; Bois J; Gulati R; Prasad A; Best PJM; Bell MR; Rihal CS; Prasad M; Ahmad A; Lerman LO; Solseth ML; Winters JL; Dietz AB; Lerman A
    Circ Res; 2022 Feb; 130(3):326-338. PubMed ID: 34923853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina.
    Briguori C; Reimers B; Sarais C; Napodano M; Pascotto P; Azzarello G; Bregni M; Porcellini A; Vinante O; Zanco P; Peschle C; Condorelli G; Colombo A
    Am Heart J; 2006 Mar; 151(3):674-80. PubMed ID: 16504630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial.
    Aaberge L; Nordstrand K; Dragsund M; Saatvedt K; Endresen K; Golf S; Geiran O; Abdelnoor M; Forfang K
    J Am Coll Cardiol; 2000 Apr; 35(5):1170-7. PubMed ID: 10758957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.